Granahan Investment Management - Q3 2018 holdings

$1.84 Billion is the total value of Granahan Investment Management's 201 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 10.0% .

 Value Shares↓ Weighting
CSGP BuyCOSTAR CORP$56,988,000
+9.8%
135,414
+7.7%
3.09%
-1.1%
STRA BuySTRATEGIC EDUCATION$53,804,000
+78.8%
392,642
+47.4%
2.92%
+61.0%
PAYC BuyPAYCOM SOFTWARE$46,545,000
+94.6%
299,495
+23.8%
2.52%
+75.2%
EXAS BuyEXACT SCIENCES$34,854,000
+40.4%
441,642
+6.4%
1.89%
+26.5%
VRTU BuyVIRTUSA CORP$30,330,000
+38.3%
564,691
+25.4%
1.65%
+24.6%
GLOB BuyGLOBANT SA$30,029,000
+21.0%
509,058
+16.5%
1.63%
+9.0%
WW BuyWEIGHT WATCHERS$28,749,000
-19.0%
399,354
+13.8%
1.56%
-27.0%
OSIS BuyOSI SYSTEMS$28,377,000
+3.5%
371,866
+4.9%
1.54%
-6.8%
ETSY NewETSY INC$27,898,000542,972
+100.0%
1.51%
LLNW BuyLIMELIGHT NETWORKS$26,791,000
+37.5%
5,336,935
+22.4%
1.45%
+23.9%
CARB BuyCARBONITE INC$25,220,000
+18.1%
707,434
+15.6%
1.37%
+6.4%
MIME BuyMIMECAST LIMITED$23,317,000
+11.1%
556,767
+9.3%
1.26%
+0.1%
CNMD BuyCONMED CORP$22,240,000
+14.1%
280,741
+5.4%
1.21%
+2.8%
KNX NewKNIGHT-SWIFT TRANS$22,195,000643,702
+100.0%
1.20%
PCTY BuyPAYLOCITY HOLDINGS CORP$20,901,000
+40.1%
260,225
+2.6%
1.13%
+26.1%
EVH BuyEVOLENT HEALTH$20,687,000
+35.8%
728,428
+0.6%
1.12%
+22.2%
CSOD BuyCORNERSTONE ONDEMAND$19,963,000
+56.9%
351,773
+31.1%
1.08%
+41.2%
BOOM BuyDMC GLOBAL INC$19,538,000
+41.8%
478,863
+56.1%
1.06%
+27.7%
NEO BuyNEOGENOMICS$19,146,000
+20.4%
1,247,327
+2.8%
1.04%
+8.5%
RAMP NewLIVERAMP HOLDING INC$18,461,000373,621
+100.0%
1.00%
GTLS BuyCHART INDUSTRIES$17,750,000
+33.3%
226,602
+5.0%
0.96%
+20.1%
RUSHA BuyRUSH ENTERPRISES$17,096,000
+2.4%
434,891
+13.0%
0.93%
-7.7%
LOPE BuyGRAND CANYON EDUCATION$16,747,000
+4.5%
148,468
+3.4%
0.91%
-5.9%
LXFR BuyLUXFER HOLDINGS PLC$16,720,000
+453.5%
719,134
+316.2%
0.91%
+398.4%
SSTI BuySHOTSPOTTER$15,427,000
+106.0%
251,704
+27.5%
0.84%
+85.6%
PLOW BuyDOUGLAS DYNAMICS$15,164,000
+0.8%
345,431
+10.2%
0.82%
-9.2%
ROLL BuyRBC BEARINGS$14,882,000
+19.1%
98,976
+2.0%
0.81%
+7.2%
RGEN BuyREPLIGEN$14,825,000
+76.9%
267,316
+50.0%
0.80%
+59.2%
TTGT BuyTECHTARGET INC$14,239,000
+6.8%
733,238
+56.3%
0.77%
-3.7%
ARGX BuyARGENX SE ADR$13,756,000
+74.0%
181,379
+90.1%
0.75%
+56.7%
MB NewMINDBODY$13,718,000337,469
+100.0%
0.74%
OXFD BuyOXFORD IMMUNOTEC GLOBAL PLC$13,721,000
+88.3%
845,383
+49.5%
0.74%
+69.5%
XLRN BuyACCELERON PHARMA$13,642,000
+23.6%
238,379
+4.8%
0.74%
+11.3%
TITN BuyTITAN MACHINERY$13,058,000
+14.6%
843,267
+15.0%
0.71%
+3.1%
CRZO BuyCARRIZO OIL AND GAS$12,713,000
+10.9%
504,472
+22.5%
0.69%
-0.1%
KNSL BuyKINSALE CAPITAL GROUP$12,219,000
+17.9%
191,348
+1.3%
0.66%
+6.2%
CHUY BuyCHUY'S HOLDINGS INC.$12,207,000
-12.1%
465,029
+2.8%
0.66%
-20.9%
EEFT BuyEURONET$10,995,000
+71.3%
109,707
+43.2%
0.60%
+54.3%
EBIX BuyEBIX$10,897,000
+12.2%
137,674
+8.1%
0.59%
+1.0%
TNC BuyTENNANT CO$10,589,000
+4.6%
139,418
+8.8%
0.58%
-5.7%
ANGO BuyANGIO DYNAMICS$10,592,000
+1.7%
487,196
+4.1%
0.58%
-8.3%
LAWS BuyLAWSON PRODUCTS$10,203,000
+44.6%
300,986
+3.9%
0.55%
+30.4%
AIN BuyALBANY INT'L$9,787,000
+36.9%
123,111
+3.6%
0.53%
+23.2%
NVEE BuyNV5 GLOBAL$9,234,000
+143.4%
106,507
+94.6%
0.50%
+118.8%
KAMN BuyKAMAN CORP$9,115,000
-0.7%
136,489
+3.6%
0.50%
-10.5%
PUMP BuyPROPETRO HOLDING$9,081,000
+12.2%
550,711
+6.7%
0.49%
+1.2%
MOD BuyMODINE MANUFACTURING$8,955,000
+46.0%
601,018
+78.8%
0.49%
+31.4%
ENTA BuyENANTA PHARMACEUTICALS$8,830,000
-24.3%
103,320
+2.6%
0.48%
-31.9%
KIN BuyKINDRED BIOSCIENCES$8,818,000
+159.7%
632,118
+98.3%
0.48%
+133.2%
CWST BuyCASELLA WASTE SYSTEMS$8,776,000
+69.2%
282,555
+39.5%
0.48%
+52.6%
BOX BuyBOX INC$8,400,000
+43.7%
351,319
+50.2%
0.46%
+29.5%
PRO BuyPROS HOLDING$8,199,000
-3.6%
234,122
+0.7%
0.44%
-13.1%
GDI BuyGARDNER DENVER$7,999,000
+48.2%
282,249
+53.7%
0.43%
+33.5%
QTWO BuyQ2 HOLDINGS$7,751,000
+10.0%
128,005
+3.7%
0.42%
-0.7%
IMMU BuyIMMUNOMEDICS$7,687,000
-8.8%
369,021
+3.7%
0.42%
-17.9%
SIEN BuySIENTRA$7,286,000
+38.9%
305,116
+13.5%
0.40%
+25.0%
LGND BuyLIGAND PHARMACEUTICALS$7,106,000
+91.7%
25,889
+44.7%
0.39%
+73.1%
UPLD BuyUPLAND SOFTWARE$7,049,000
-2.4%
218,153
+3.8%
0.38%
-12.2%
HUBS BuyHUBSPOT$6,854,000
+23.7%
45,407
+2.7%
0.37%
+11.4%
DXCM BuyDEXCOM INC$6,665,000
+51.9%
46,596
+0.9%
0.36%
+37.1%
RTEC BuyRUDOLPH TECH$6,398,000
-13.4%
261,690
+4.9%
0.35%
-22.0%
HBIO BuyHARVARD BIOSCIENCE$5,851,000
+1.7%
1,114,490
+3.6%
0.32%
-8.6%
MGNX BuyMACROGENICS$5,294,000
+6.8%
246,916
+2.9%
0.29%
-4.0%
PODD BuyINSULET CORP$5,179,000
+1518.4%
48,884
+1209.2%
0.28%
+1378.9%
QTS BuyQTS REALTY TRUST$5,134,000
+15.9%
120,316
+7.3%
0.28%
+4.5%
CEVA BuyCEVA$5,136,000
+11.6%
178,629
+17.2%
0.28%
+0.7%
ESPR BuyESPERION THERAPEUTICS$4,945,000
+17.5%
111,450
+3.8%
0.27%
+5.9%
HTGM BuyHTG MOLECULAR DIAGNOSTICS$4,753,000
+59.3%
941,170
+2.8%
0.26%
+43.3%
AFHIF BuyATLAS FINANCIAL HOLDINGS$4,442,000
+45.4%
441,971
+26.5%
0.24%
+31.0%
ADSW BuyADVANCED DISPOSAL SERVICES INC$4,337,000
+15.0%
160,158
+5.2%
0.24%
+3.5%
ECPG BuyENCORE CAP GROUP$3,690,000
+3.6%
102,939
+5.8%
0.20%
-7.0%
GTTN BuyGTT COMMUNICATION$3,639,000
+25.3%
83,853
+29.9%
0.20%
+12.6%
VCEL BuyVERICEL CORPORATION$3,490,000
+52.1%
246,611
+4.2%
0.19%
+37.0%
AUTL BuyAUTOLUS$3,090,000
+18.4%
100,762
+3.4%
0.17%
+7.0%
CTMX BuyCYTOMX THERAPEUTICS$3,091,000
-16.8%
167,088
+2.8%
0.17%
-25.0%
COLL BuyCOLLEGIUM PHARMACEUTICAL$2,904,000
-4.5%
197,037
+54.6%
0.16%
-13.7%
TER BuyTERADYNE$2,898,000
+9.5%
78,358
+12.7%
0.16%
-1.3%
BGCP BuyBGC PARTNERS INC$2,824,000
+30.1%
238,941
+24.6%
0.15%
+16.8%
PFIE BuyPROFIRE ENERGY$2,730,000
+8.5%
855,743
+15.0%
0.15%
-2.6%
HDSN BuyHUDSON TECHNOLOGIES$2,726,000
+31.0%
2,129,906
+105.8%
0.15%
+18.4%
CLDR NewCLOUDERA, INC$2,587,000146,545
+100.0%
0.14%
ZFGN BuyZAFGEN INC$2,534,000
+255.9%
216,742
+211.2%
0.14%
+218.6%
IPHI BuyINPHI$2,501,000
+44.8%
65,854
+24.4%
0.14%
+30.8%
REI BuyRING ENERGY$2,435,000
-19.1%
245,728
+3.0%
0.13%
-27.1%
SGMO BuySANGAMO BIOSCIENCES$2,428,000
+21.0%
143,267
+1.4%
0.13%
+9.1%
CTSO NewCYTOSORBENTS CORPORATION$2,416,000187,300
+100.0%
0.13%
BLFS BuyBIOLIFE SOLUTIONS$2,366,000
+73.8%
135,181
+13.3%
0.13%
+56.1%
XERS BuyXERIS PHARMACEUTICALS$2,306,000
-7.1%
131,145
+0.3%
0.12%
-16.1%
SLAB BuySILICON LABORATORIES INC$2,273,000
-6.3%
24,758
+1.6%
0.12%
-15.8%
CDTX BuyCIDARA THERAPEUTICS$2,113,000
-10.9%
480,131
+5.3%
0.12%
-19.6%
FNSR BuyFINISAR$2,084,000
+8.3%
109,411
+2.3%
0.11%
-2.6%
TRUP BuyTRUPANION$1,912,000
+19.4%
53,500
+28.9%
0.10%
+7.2%
APPS BuyDIGITAL TURBINE INC$1,859,000
-12.1%
1,499,144
+7.1%
0.10%
-20.5%
FENC BuyFENNEC PHARMACEUTICALS$1,830,000
+207.6%
223,123
+291.4%
0.10%
+175.0%
PRTK BuyPARATEK PHARMACEUTICALS$1,781,000
-1.1%
183,615
+4.0%
0.10%
-11.0%
STIM BuyNEURONETICS$1,763,000
+562.8%
55,000
+450.0%
0.10%
+500.0%
NMRK BuyNEWMARK$1,735,000
-7.6%
155,082
+17.5%
0.09%
-16.8%
ITRM BuyITERUM THERAPEUTICS$1,661,000
-35.4%
250,717
+4.1%
0.09%
-41.9%
SPRO BuySPERO THERAPEUTICS$1,651,000
-25.5%
157,058
+3.9%
0.09%
-32.8%
VST BuyVISTRA ENERGY$1,595,000
+18.7%
64,095
+12.9%
0.09%
+7.4%
CTG BuyCOMPUTER TASK GROUP$1,582,000
-32.4%
302,982
+0.2%
0.09%
-39.0%
JYNT BuyJOINT CORP$1,387,000
+4.7%
162,197
+0.2%
0.08%
-6.2%
ENSV BuyENSERVCO$1,295,000
-31.8%
1,639,079
+0.2%
0.07%
-38.6%
AKAM BuyAKAMAI$1,278,000
+20.3%
17,472
+20.5%
0.07%
+7.8%
MLNT BuyMELINTA THERAPEUTICS$1,250,000
-35.3%
316,561
+4.1%
0.07%
-41.4%
LYV BuyLIVE NATION INC$1,153,000
+54.8%
21,175
+38.1%
0.06%
+40.0%
NVTRQ NewNUVECTRA CORP$1,123,00051,100
+100.0%
0.06%
FLGT BuyFULGENT GENETICS$894,000
-5.0%
227,509
+0.1%
0.05%
-14.0%
JNCE BuyJOUNCE THERAPEUTICS$879,000
-12.8%
135,280
+2.8%
0.05%
-21.3%
ANGI BuyANGI HOME SERVICES$704,000
+248.5%
29,968
+128.7%
0.04%
+216.7%
TOCA BuyTOCAGEN$662,000
+67.2%
42,479
+0.1%
0.04%
+50.0%
NewNABRIVA THERAPEUTICS PLC$668,000247,276
+100.0%
0.04%
MTCH BuyMATCH GROUP$653,000
+106.6%
11,269
+38.0%
0.04%
+84.2%
AVEO BuyAVEO PHARMACEUTICALS$595,000
+46.6%
179,853
+0.2%
0.03%
+33.3%
AKAOQ BuyACHAOGEN$585,000
-52.0%
146,588
+4.1%
0.03%
-56.2%
GHDX NewGENOMIC HEALTH INC$463,0006,600
+100.0%
0.02%
CGIX BuyCANCER GENETICS INC$289,000
+17.5%
278,260
+0.7%
0.02%
+6.7%
HQY NewHEALTHEQUITY$244,0002,580
+100.0%
0.01%
IONS NewIONIS PHARMACEUTICALS$223,0004,316
+100.0%
0.01%
PTI BuyPROTEOSTASIS THERAPEUTICS$197,000
-13.6%
81,849
+0.2%
0.01%
-21.4%
ASNS BuyARSANIS$169,000
-53.7%
104,244
+3.6%
0.01%
-59.1%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-11-13
Signatures

The EDGAR filing(s) were signed by:

About Granahan Investment Management

Granahan Investment Management is a Boston-based investment firm that specializes in small-cap growth equity strategies. The firm was founded in 1985 by Jane Granahan and her late husband, Gerald Granahan, who was a pioneer in the small-cap growth investing space. Today, the firm is led by CEO and Chief Investment Officer Gary Hatton, who has been with the firm since 1993.

Granahan Investment Management has a team of experienced investment professionals who conduct extensive research to identify high-growth companies with strong fundamentals and attractive valuations. The firm's investment process is focused on bottom-up stock selection, with a long-term investment horizon. The team seeks to invest in companies with sustainable competitive advantages, strong management teams, and attractive growth prospects.

The firm manages several mutual funds, including the Granahan Small Cap Advantage Fund, which has a 5-star Morningstar rating and has outperformed its benchmark over the long term. The firm also manages separate accounts for institutional clients.

Granahan Investment Management has a strong culture of integrity, teamwork, and client service. The firm's investment professionals are committed to delivering superior investment results and building long-term relationships with their clients.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
COSTAR GROUP INC42Q3 20234.7%
SPS COMM INC42Q3 20233.5%
EURONET WORLDWIDE, INC42Q3 20231.7%
OSI SYSTEMS INC42Q3 20232.4%
RBC BEARINGS INC42Q3 20231.5%
DOUGLAS DYNAMICS INC42Q3 20231.0%
PROS HOLDINGS INC42Q3 20230.8%
RADWARE LTD42Q3 20231.3%
RUSH ENTERPRISES INC42Q3 20231.1%
POWER INTEGRATIONS INC42Q3 20230.9%

View Granahan Investment Management's complete holdings history.

Latest significant ownerships (13-D/G)
Granahan Investment Management Q3 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Evolent Health, Inc.February 14, 20233,155,2113.1%
SHOTSPOTTER, INCFebruary 14, 2023552,6254.5%
ALTA EQUIPMENT GROUP INC.February 14, 20221,453,5474.5%
CF Finance Acquisition Corp.Sold outFebruary 14, 202200.0%
Cricut, Inc.February 14, 20221,779,1274.9%
NAUTILUS, INC.Sold outFebruary 14, 202200.0%
ONESPAWORLD HOLDINGS LtdFebruary 14, 20222,978,8074.0%
Victory Capital Holdings, Inc.February 14, 2022879,6081.3%
dMY Technology Group, Inc. IISold outMay 11, 202100.0%
RumbleON, Inc.January 21, 202140,8771.9%

View Granahan Investment Management's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-04-11
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Granahan Investment Management's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (1843060000.0 != 1843059000.0)

Export Granahan Investment Management's holdings